Who owns LENZ THERAPEUTICS INC?
- Ticker: LENZ
- CUSIP Number: 52635n103
Tip: Access positions for across all investors
Analyze quarterly positions in Lenz Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lenz Therapeutics stock
Who bought or sold LENZ THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 4.2M | $99M | 0% | Sep 2024 |
|
| Falcon Edge Capital | 3.6M | $86M | 0% | Sep 2024 |
|
| EcoR1 Capital | 1.2M | $21M | 0% | Jun 2024 |
|
| Samsara BioCapital | 1.2M | $29M | 0% | Sep 2024 |
|
| 72 Investment Holdings | 1.0M | $24M | 0% | Sep 2024 |
|
| BlackRock | 960k | $17M | 298% | Jun 2024 |
|
| Vanguard Group | 956k | $17M | 362% | Jun 2024 |
|
| BlackRock | 930k | $22M | 100% | Sep 2024 |
|
| Point72 Asset Management | 865k | $21M | 0% | Sep 2024 |
|
| Tang Capital Management | 767k | $18M | 3% | Sep 2024 |
|
| T. Rowe Price Associates | 449k | $11M | 100% | Sep 2024 |
|
| Geode Capital Management | 338k | $8.0M | -6% | Sep 2024 |
|
| State Street Corporation | 244k | $4.2M | 274% | Jun 2024 |
|
| Ikarian Capital | 205k | $4.9M | 0% | Sep 2024 |
|
| Northern Trust | 130k | $3.1M | 219% | Sep 2024 |
|
| Charles Schwab Investment Management | 123k | $2.9M | 197% | Sep 2024 |
|
| Alyeska Investment Group | 122k | $2.9M | -62% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 107k | $2.5M | 100% | Sep 2024 |
|
| Wealth Enhancement Advisory Services | 83k | $1.4M | 100% | Jun 2024 |
|
| Morgan Stanley | 66k | $1.1M | 143% | Jun 2024 |
|
| BML Capital Management | 60k | $1.4M | -6% | Sep 2024 |
|
| Vivaldi Capital Management | 59k | $1.4M | 0% | Sep 2024 |
|
| Renaissance Technologies | 49k | $1.2M | -18% | Sep 2024 |
|
| BBR Partners | 40k | $950k | 100% | Sep 2024 |
|
| Two Sigma Investments | 34k | $593k | 100% | Jun 2024 |
|
| Dimensional Fund Advisors | 34k | $811k | -8% | Sep 2024 |
|
| Bank of New York Mellon | 30k | $704k | -25% | Sep 2024 |
|
| TD Asset Management | 28k | $681k | 100% | Sep 2024 |
|
| Kestra Private Wealth Services | 28k | $653k | 100% | Sep 2024 |
|
| American Century Companies | 24k | $567k | 100% | Sep 2024 |
|
| Nuveen Asset Management | 23k | $400k | 100% | Jun 2024 |
|
| Bridgeway Capital Management | 22k | $379k | 0% | Jun 2024 |
|
| Wall Street Access Asset Management | 21k | $493k | 100% | Sep 2024 |
|
| Bank of America Corporation | 20k | $471k | 19% | Sep 2024 |
|
| Rhumbline Advisers | 18k | $419k | 5% | Sep 2024 |
|
| Barclays | 17k | $391k | 273% | Sep 2024 |
|
| Goldman Sachs Group | 13k | $229k | 100% | Jun 2024 |
|
| Jane Street | 12k | $286k | 100% | Sep 2024 |
|
| Squarepoint Ops | 11k | $181k | 100% | Jun 2024 |
|
| GSA Capital Partners | 10k | $246k | 100% | Sep 2024 |
|
| Citigroup | 9.1k | $217k | -50% | Sep 2024 |
|
| MetLife Investment Advisors | 7.7k | $182k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 6.9k | $164k | 325% | Sep 2024 |
|
| Wells Fargo & Company | 5.9k | $140k | 4% | Sep 2024 |
|
| Jpmorgan Chase & Co | 5.7k | $135k | 5% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 5.4k | $127k | 1% | Sep 2024 |
|
| SG Americas Securities | 4.5k | $107k | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 3.5k | $83k | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.6k | $63k | -84% | Sep 2024 |
|
| Royal Bank of Canada | 1.3k | $27k | -4% | Sep 2024 |
|
| Summit Investment Advisors | 1.2k | $29k | 0% | Sep 2024 |
|
| Atlantic Trust | 1.1k | $27k | 100% | Sep 2024 |
|
| California State Teachers Retirement System | 910.00 | $22k | 0% | Sep 2024 |
|
| Tower Research Capital | 866.00 | $15k | 92% | Jun 2024 |
|
| Raleigh Capital Management | 500.00 | $12k | 100% | Sep 2024 |
|
| Planned Solutions | 217.00 | $5.2k | 100% | Sep 2024 |
|
| Amalgamated Bank | 135.00 | $3.0k | 0% | Sep 2024 |
|
| GAMMA Investing | 82.00 | $1.9k | 165% | Sep 2024 |
|
| Sterling Capital Management | 40.00 | $950.000000 | 100% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 28.00 | $665.000000 | 0% | Sep 2024 |
|
| CWM | 26.00 | $999.999000 | 225% | Sep 2024 |
|
| NISA Investment Advisors | 22.00 | $522.000600 | 100% | Sep 2024 |
|
| Russell Investments | 13.00 | $225.000100 | 100% | Jun 2024 |
|
| SRS Capital Advisors | 12.00 | $285.000000 | 0% | Sep 2024 |
|
| Smartleaf Asset Management | 11.00 | $264.000000 | 0% | Sep 2024 |
|
| Capital Performance Advisors | 6.00 | $142.000200 | 100% | Sep 2024 |
|
| Advisor Group Holdings | 2.00 | $47.000000 | 0% | Sep 2024 |
|
Who sold out of Lenz Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | Jun 2024 | 100k | $1.7M |
| Jump Financial | Jun 2024 | 23k | $391k |
| Marshall Wace | Jun 2024 | 23k | $390k |
| Deerfield Management Company | Jun 2024 | 17k | $300k |
| Engineers Gate Manager | Jun 2024 | 15k | $253k |
| Qube Research & Technologies | Mar 2024 | 982.00 | $22k |
| Lazard Asset Management | Jun 2024 | 12.00 | $0 |